Cargando…
Purinergic Regulation of Endothelial Barrier Function
Increased vascular permeability is a hallmark of several cardiovascular anomalies, including ischaemia/reperfusion injury and inflammation. During both ischaemia/reperfusion and inflammation, massive amounts of various nucleotides, particularly adenosine 5′-triphosphate (ATP) and adenosine, are rele...
Autores principales: | Aslam, Muhammad, Gündüz, Dursun, Troidl, Christian, Heger, Jacqueline, Hamm, Christian W., Schulz, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865261/ https://www.ncbi.nlm.nih.gov/pubmed/33530557 http://dx.doi.org/10.3390/ijms22031207 |
Ejemplares similares
-
cAMP controls the restoration of endothelial barrier function after thrombin‐induced hyperpermeability via Rac1 activation
por: Aslam, Muhammad, et al.
Publicado: (2014) -
Inhibition of Protein Prenylation of GTPases Alters Endothelial Barrier Function
por: Aslam, Muhammad, et al.
Publicado: (2019) -
Role of PI3K/Akt and MEK/ERK Signalling in cAMP/Epac-Mediated Endothelial Barrier Stabilisation
por: Gündüz, Dursun, et al.
Publicado: (2019) -
Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y(12) Receptor and Aggregation
por: Gündüz, Dursun, et al.
Publicado: (2017) -
Hypoxia induces purinergic receptor signaling to disrupt endothelial barrier function
por: Raghavan, Somasundaram, et al.
Publicado: (2022)